Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer
NCT01415739 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2019-01-24
Summary
This research studies protein in tumor samples from patients with non-small cell lung cancer. Finding specific proteins in tumor tissue samples from patients with cancer may help doctors tell what type of lung cancer a patient has and plan better treatment.
Conditions
Interventions
- OTHER
-
laboratory biomarker analysis
Correlative studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Alliance for Clinical Trials in Oncology
lead OTHER
Principal Investigators
-
Daniel J. Boffa, MD · Smilow Cancer Hospital at Yale-New Haven
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-08-31
Countries
- United States
Study Locations
More Related Trials
-
The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer
NCT02380196 ·Status: COMPLETED
-
Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 ·Status: COMPLETED
-
Circulating Tumor Cells in Lung Cancer
NCT01658332 ·Status: TERMINATED ·Phase: NA
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
NCT00471978 ·Status: RECRUITING
-
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529 ·Status: RECRUITING
-
LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
NCT06778512 ·Status: RECRUITING
-
A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery
NCT05872763 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
Metabolic and Microbial Profiling of Lung Cancer
NCT03998189 ·Status: TERMINATED ·Phase: NA
-
Collection of Blood Samples in Patients With Non-small Cell Lung Cancer
NCT03492801 ·Status: TERMINATED
-
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
NCT00897143 ·Status: WITHDRAWN
-
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
NCT04712877 ·Status: RECRUITING
-
A Multi-Center Trial of the ProLung Test™
NCT01566682 ·Status: COMPLETED
-
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
NCT05250817 ·Status: COMPLETED
-
Fluid Biopsy for the Diagnosis of Lung Cancer
NCT04162678 ·Status: TERMINATED
-
Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC
NCT00483015 ·Status: COMPLETED
-
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00450281 ·Status: COMPLETED
-
Specimen Banking From Patients With Lung Cancer
NCT01585675 ·Status: RECRUITING
-
Study of Tumor Samples From Patients With Lung Cancer
NCT00900328 ·Status: COMPLETED
-
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
NCT02597738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
NCT01450553 ·Status: UNKNOWN
-
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01139944 ·Status: COMPLETED
-
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
NCT01173458 ·Status: COMPLETED
-
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
NCT00003006 ·Status: COMPLETED